Pharm-Rx D-Chiro Inositol
- Molecular Formula
- C₆H₁₂O₆
Pharm-Rx D-Chiro Inositol is a product that signals transduction and is presented in the middle of the insulin signaling process in the body. Market segments for this product include food and nutrition, with claimed health benefits such as reducing blood sugar levels and improving menstrual health. Labeling claims include being vegetarian, vegan, eco-friendly, non-toxic, non-GMO, BSE-free, TSE-free, and allergen-free. End uses for this product encompass dietary supplements, syrups, waffles, butter spreads, and chocolates.
Properties
- Physical Form
- Powder
- Pharma and Nutraceuticals Functions
- Supplement
Product families
Applications
- Oral
- Bakery
- Confectionery
- Dairy
- Nutraceuticals & Supplements
Product Families
- Supplements & Functional Ingredients
- Functional Ingredients
Other characteristics
- Features
Blood Glucose Management, Broad pH Stability, Free of Major Allergens, Suitable for Vegans, Suitable for Vegetarian Foods, Temperature Stability
- Synonyms
D-(+)- chiro-Inositol, (+)- chiro-Inositol, D- chiro-Inositol, D-Inositol
- Ingredient Name
- D-Chiro Inositol
- Labeling Claims
Allergen-free, BSE-free, Environmentally Friendly, Natural, Naturally Derived, Non-GMO, Non-Toxic, Plant-Based, TSE-free, Vegan, Vegetarian; Allergen-free; BSE-free; Environmentally Friendly; Natural; Naturally Derived; Non-GMO; Non-Toxic; Plant-Based; TSE-free; Vegan; Vegetarian
- Ingredient Origin
- Natural Origin, Plant Origin
- Natural Origin
- Plant Origin
- Benefit Claims (Health)
Improves Menstrual Health, Reduce Blood Sugar Levels; Improves Menstrual Health; Reduce Blood Sugar Levels
- Certifications & Compliance
California Proposition 65, FDA 29 CFR 1910.1200, GMP
- Markets
- Food & Nutrition
- Healthcare & Pharma
- Appearance
- Whitish powder
- Soluble In
- Water Soluble
- Dosage Form
- Powder & Powder Blends
- Tablets
- Technology
- Food Ingredients
- Pharmaceuticals & Nutraceuticals
- FDA Disclaimer
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
- Country of Origin
- South Korea
- HIGHLIGHTS
DCI is a signal transduction presented in the middle of the insulin signaling process in the body; When normal people consume MI, some MI are converted into DCI in the human body, and DCI controls blood sugar and physiological and PCOS improvement; People who have problems with insulin homeostasis (insulin resistance or diabetic patients) can not control blood sugar control, physiological control and PCOS improvement, etc. because DCI conversion is not possible even after directly taking MI; Direct ingestion of Pl or DCI positively affects blood sugar, physiological and PCOS improvement
- Chemical Inventories
- EINECS (EU)
- ENCS (Japan)
- TCSI (Taiwan)
- Food Ingredients Features
- Blood Glucose Management
- Broad pH Stability
- Free of Major Allergens
- Suitable for Vegans
- Suitable for Vegetarian Foods
- Temperature Stability
- Food Ingredients Functions
- Supplement
- Certifications and Compliance
- California Proposition 65
- FDA 29 CFR 1910.1200
- GMP
- Food and Nutrition Applications
- Butter Spreads
- Chocolates
- Dietary Supplements
- Syrups
- Waffles
Technical data
Table 1 of 4
1 row| Characteristic | Value |
|---|---|
| Molecular Weight | 180.16 |
Table 2 of 4
5 rows| Characteristic | Value | Unit | Method |
|---|---|---|---|
| Yeast & Molds Count | max. 100 | cfu/g | SPC method (PDA) |
| Total Microbial Count | max. 1,000 | cfu/g | SPC method (PCA) |
| Salmonella | Negative | cfu/g | RV, TT Broth method |
| Eschericha Coli | Negative | cfu/g | EC method |
| Coliforms | Negative | cfu/g | BGLB method |
Table 3 of 4
3 rows| Characteristic | Value | Unit |
|---|---|---|
| Total Fat (as Crude Fat) | 0 | % /100g |
| Sodium Content | 0.2 | mg/100g |
| Carbohydrates | 100 | % /100g |
Table 4 of 4
13 rows| Characteristic | Value | Unit | Method |
|---|---|---|---|
| Tapped Density | min. 0.85 | g/ml | Tap Density Volumeter Method |
| Residue on Ignition | max. 5.0 | % | Electric furnace (550C, Over night) |
| Purity Content | min. 95 | % | HPLC |
| Particle size (Through 80 mesh) | min. 90 | % | Mesh |
| Particle size (Through 60 mesh) | min. 100 | % | Mesh |
| Particle size (Through 40 mesh) | min. 100 | % | Mesh |
| Molecular Mass | 180 | — | — |
| Mercury Content | max. 0.1 | ppm | Mercury Analyzer |
| Loss on Drying | max. 5.0 | % | Drying (105 C, 4hr) |
| Lead Content | max. 3.0 | ppm | ICP |
| Cadmium Content | max. 1.0 | ppm | ICP |
| Bulk Density | min. 0.50 | g/ml | Bulk Density Volumeter Method |
